We are live on ! Find out more
AGRX

Agile Therapeutics
AGRX

Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

45 hedge funds and large institutions have $113M invested in Agile Therapeutics in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 6

12% less funds holding

Funds holding: 51 → 45 (-6)

23% less capital invested

Capital invested by funds: $147M → $113M (-$34.3M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

Holders
45
Holders Change
-6
Holders Change %
-11.76%
% of All Funds
1.26%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
2
Increased
14
Reduced
6
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
+$2.93M
2
HCMT
Highland Capital Management (Texas)
Texas
+$959K
3
Northern Trust
Northern Trust
Illinois
+$728K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$391K
5
State Street
State Street
Massachusetts
+$195K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$7.35M
2
FCMI
Foresite Capital Management II
California
-$428K
3
Goldman Sachs
Goldman Sachs
New York
-$405K
4
Renaissance Technologies
Renaissance Technologies
New York
-$390K
5
RFC
Russell Frank Company
Washington
-$254K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$282K +$88.8K +5 +31%
BIM
27
BlackRock Investment Management
Delaware
$245K – – –
TCIM
28
TIAA CREF Investment Management
New York
$220K -$107K -6 -27%
CC
29
Caxton Corporation
New Jersey
$155K +$53.3K +3 +33%
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$127K -$17.8K -1 -10%
TA
31
Teachers Advisors
New York
$100K – – –
Charles Schwab
32
Charles Schwab
California
$91K – – –
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$63K +$35.5K +2 +67%
Morgan Stanley
34
Morgan Stanley
New York
$53K -$142K -8 -67%
NFA
35
Nationwide Fund Advisors
Ohio
$44K – – –
AIG
36
American International Group
New York
$41K – – –
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$35K – – –
BA
38
BlackRock Advisors
Delaware
$34K – – –
Deutsche Bank
39
Deutsche Bank
Germany
$19K -$53.3K -3 -75%
UBS Group
40
UBS Group
Switzerland
$19K – – –
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$13.9K +$17.8K +1 New
LTFS
42
Ladenburg Thalmann Financial Services
Florida
$10K – – –
Wells Fargo
43
Wells Fargo
California
$10K – – –
MFS
44
MSI Financial Services
Massachusetts
$7K – – –
Walleye Trading
45
Walleye Trading
New York
$7K +$17.8K +1 New
TRCT
46
Tower Research Capital (TRC)
New York
$6K – – –
Citigroup
47
Citigroup
New York
$4K – – –
Bank of America
48
Bank of America
North Carolina
$1K – – –
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 – – –
FCMI
50
Foresite Capital Management II
California
– -$428K -25 Closed
1
2
3

AGRX Hedge Fund Activity: Q3 2015 in Review

45 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Agile Therapeutics (AGRX) for Q3 2015, worth a combined $113M — down 23% from $147M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of AGRX and 2 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 14 added.

The largest buyer was Opaleye Management, adding an estimated $2.93M. The largest seller was RA Capital Management, cutting an estimated $7.35M.

  • 45 institutional investors held Agile Therapeutics (AGRX) as of Q3 2015, down from 51 in Q2 2015.
  • Funds reported $113M of Agile Therapeutics stock for Q3 2015, down 23% quarter-over-quarter.
  • 2 funds opened new Agile Therapeutics positions in Q3 2015 and 8 closed out, a net change of -6 holders.
  • The largest Agile Therapeutics buyer in Q3 2015 was Opaleye Management, an estimated $2.93M added.
  • The largest Agile Therapeutics seller in Q3 2015 was RA Capital Management, an estimated $7.35M sold.

Based on aggregated 13F filings for Q3 2015.